DCLK1 and cancer: Zhao et al. [79] reported that the metabolic aberration mainly enhanced glycolysis, promoted the expression of doublecortin-like kinase 1, the marker for the stemness, and maintained the CSC and EMT phenotypes in the gemcitabine-resistant cancer cells via maintenance of low-levels of reactive oxygen species.